XLVE:CA:TSX-Mulvihill U.S. Health Care Enh Y ETF (CAD)

ETF | Others |

Last Closing

CAD 8.52

Change

0.00 (0.00)%

Market Cap

N/A

Volume

600.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.11 (+0.39%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.31B
PHYS-U:CA Sprott Physical Gold Trust

-0.13 (-0.65%)

CAD 4.76B
XEQT:CA iShares Core Equity Portfolio

-0.03 (-0.09%)

CAD 4.70B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.04 (-0.11%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.48 (-2.00%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.06 (+0.57%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.06 (-0.26%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.53B

ETFs Containing XLVE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.43% 15% F 21% F
Dividend Return 0.00% 11% F 4% F
Total Return 1.43% 14% F 20% F
Trailing 12 Months  
Capital Gain 0.24% 9% A- 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.24% 8% B- 18% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.67% 9% A- 16% F
Dividend Return -3.67% 9% A- 11% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.26% 70% C- 88% B+
Risk Adjusted Return -69.71% 4% F 3% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.